AKEEGA
As listed in the register: AKEEGA
100 mg + 500 mg · tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Niraparib (Niraparib Tosylate) + Abiraterone Acetate
- Made by
- Janssen Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Janssen Inc |
|---|---|
| Active substance | Niraparib (Niraparib Tosylate) + Abiraterone Acetate |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 100 mg + 500 mg |
| Form | tablet |
| Classification | L01XK52 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02538563 |
| DPD drug code | 102728 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet2 products
- 50 mg + 500 mg
- 100 mg + 500 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Niraparib (Niraparib Tosylate) + Abiraterone Acetate